Found: 5
Select item for more details and to access through your institution.
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0599-z
- By:
- Publication type:
- Article
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0555-y
- By:
- Publication type:
- Article
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 320, doi. 10.1159/000514313
- By:
- Publication type:
- Article
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 5, p. 1, doi. 10.1038/s41419-020-2549-2
- By:
- Publication type:
- Article
PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 4, p. 1, doi. 10.1038/s41419-018-0435-y
- By:
- Publication type:
- Article